CHOSEN trial results paves the way for a nationwide phase 3 trial

Press/Media: Research

Description

Professor Craig Smith, theme lead for stroke at our centre and a consultant in stroke medicine at Northern Care Alliance NHS Foundation Trust presented the findings from the CHOSEN trial at the UK Stroke Forum in Birmingham earlier this month. CHOSEN (CHlorhexidine Or toothpaSte, manual or powered brushing to prEvent pNeumonia complicating stroke; ISRCTN52421361) is a multicentre, randomised clinical trial in the North West of England funded by the NIHR and led by Professor Smith. 

Period20 Dec 2023

Media coverage

1

Media coverage

  • TitleCHOSEN trial results paves the way for a nationwide phase 3 trial
    Media name/outletGeoffrey Jefferson Brain Research Centre
    Media typeWeb
    Country/TerritoryUnited Kingdom
    Date20/12/23
    DescriptionProfessor Craig Smith, theme lead for stroke at our centre and a consultant in stroke medicine at Northern Care Alliance NHS Foundation Trust presented the findings from the CHOSEN trial at the UK Stroke Forum in Birmingham earlier this month. CHOSEN (CHlorhexidine Or toothpaSte, manual or powered brushing to prEvent pNeumonia complicating stroke; ISRCTN52421361) is a multicentre, randomised clinical trial in the North West of England funded by the NIHR and led by Professor Smith.
    URLhttps://gjbrainresearch.org/2023/12/20/chosen-trial-results-paves-the-way-for-a-nationwide-phase-3-trial/
    PersonsCraig Smith